title: Conjugation of lipid and CpG-containing oligonucleotide yields an efficient method for liposome incorporation.
abstract: For optimal stimulation of T cells, protein-based vaccines must deliver protein antigens to antigen-presenting cells while simultaneously providing immunostimulatory signals. Listeriolysin O (LLO)-containing liposomes have been utilized to efficiently deliver protein antigens to the cytosolic pathway for antigen processing and major histocompatibility complex class I-dependent presentation while codelivering immunostimulatory CpG-oligodeoxyribonuceotides (ODNs). In this report, we describe the synthesis of lipid-CpG-ODN conjugates utilizing maleimide-phosphatidylethanolamine (PE) lipids and 5'-sulfhdryl-containing CpG-ODNs as a method for facile incorporation of CpG-ODNs in liposomal vaccine carriers, an alternative to co-encapsulation inside liposomes and as a means to enhance delivery of CpG-ODNs to their major receptor, Toll-like receptor 9 (TLR9), in the endosome. The characterization and biological evaluation of the vaccine delivery system made of liposomes, which contain the lipid-CpG-ODN conjugates inserted in the liposomal membrane, is described. We demonstrate in vitro in bone marrow derived macrophages that the lipid-CpG-ODN conjugates incorporated onto the liposome bilayers interact with their receptor TLR9 as readily as liposome-encapsulated ODNs and exert their immunostimulatory capabilities. The liposomal vaccine delivery systems were evaluated in mice using ovalbumin (OVA) as a model antigen, and the results indicate equally robust OVA-specific cytotoxic T lymphocyte responses and similar Th1 immune skewing capabilities between liposomes containing lipid-conjugated or encapsulated CpG-ODNs. Overall, this work indicates that conjugating PE lipids and CpG-ODNs results in an efficient method that allows facile incorporation of CpG-ODNs into a liposome-based delivery platform while retaining the immune-stimulating capabilities of CpG-ODNs.
authors: Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109, United States.
authors: Chasity D
authors: CD
authors: Andrews
authors: Chester J
authors: CJ
authors: Provoda
authors: Gary
authors: G
authors: Ott
authors: Kyung-Dall
authors: KD
authors: Lee
references: Adv Drug Deliv Rev. 2008 Apr 29;60(7):795-804
references: 18262306
references: Pharm Res. 2004 Sep;21(9):1519-30
references: 15497674
references: Annu Rev Immunol. 2003;21:305-34
references: 12471050
references: Eur J Immunol. 2000 Jul;30(7):1939-47
references: 10940883
references: Mol Pharm. 2005 Jan-Feb;2(1):74-82
references: 15804180
references: Immunity. 2008 Mar;28(3):315-23
references: 18342006
references: Nat Immunol. 2004 Feb;5(2):190-8
references: 14716310
references: Cancer Immunol Immunother. 2007 Aug;56(8):1251-64
references: 17242927
references: Nat Biotechnol. 2000 May;18(5):509-14
references: 10802617
references: Biochim Biophys Acta. 2002 Jun 13;1563(1-2):7-17
references: 12007619
references: Nat Immunol. 2006 Jan;7(1):49-56
references: 16341217
references: J Immunol. 2001 Jul 1;167(1):66-74
references: 11418633
references: Biochim Biophys Acta. 1992 Jan 31;1103(2):185-97
references: 1543703
references: Mol Pharm. 2004 Jan 12;1(1):2-8
references: 15832496
references: Biochim Biophys Acta. 2001 Feb 9;1510(1-2):152-66
references: 11342155
references: Vaccine. 2003 Jul 4;21(23):3319-29
references: 12804863
references: Annu Rev Immunol. 2002;20:709-60
references: 11861616
references: Ann N Y Acad Sci. 1958 Oct 13;75(1):110-4
references: 13627807
references: Trends Immunol. 2006 Nov;27(11):525-32
references: 16979939
references: Nat Rev Immunol. 2001 Nov;1(2):135-45
references: 11905821
references: Nature. 2008 Dec 4;456(7222):658-62
references: 18820679
references: Biochim Biophys Acta. 1989 Jan 16;978(1):85-90
references: 2914133
references: Bioconjug Chem. 2002 Sep-Oct;13(5):966-74
references: 12236778
references: J Immunol. 2001 Sep 15;167(6):3324-8
references: 11544321
references: Bioconjug Chem. 2007 Jan-Feb;18(1):77-83
references: 17226959
references: Biochemistry. 1990 May 22;29(20):4929-39
references: 2163672
references: Trends Immunol. 2009 Jan;30(1):23-32
references: 19059004
references: J Control Release. 2010 Dec 1;148(2):219-25
references: 20620181
references: Pharm Res. 2008 Mar;25(3):551-62
references: 17912489
references: Mol Pharm. 2009 Jul-Aug;6(4):1160-9
references: 19415922
references: Nat Immunol. 2008 Dec;9(12):1407-14
references: 18931679
references: Ann N Y Acad Sci. 1994 Aug 15;730:15-25
references: 8080169
references: Vaccine. 1995 Nov;13(16):1557-62
references: 8578842
references: Nat Rev Microbiol. 2007 Jul;5(7):505-17
references: 17558426
references: J Biol Chem. 1996 Mar 29;271(13):7249-52
references: 8631734
references: J Exp Med. 1997 Oct 6;186(7):1159-63
references: 9314564
references: Nat Immunol. 2007 Jul;8(7):772-9
references: 17572678